leisure time -WSS

leisure time

author：leisure time 2025-09-28 18:47:30 - browse：76426

A yellow air ambulance in the sky. -- health business coverage from STAT — Ed Uthman

After Congress officially outlawed surprise medical bills last year, there’s been endless, litigious debate as to how health insurance companies and providers should settle their differences over how much to pay for out-of-network medical bills. Now, an air ambulance provider that already went through the arbitration process is suing Blue Cross Blue Shield of Arizona, which the company says won’t pay the agreed-upon amounts.

The idea behind the arbitration process is to protect patients from getting slapped with massive bills when providers and insurers can’t agree on how much a given health care service is worth. Instead of billing patients for the difference, the government established an independent dispute resolution process in which a third party picks between the provider’s and the payer’s offers for a claim.

This case is one of the first where the provider isn’t disputing the arbitration process itself, or the amount chosen. Instead, the air ambulance company, PHI Health, says BCBS of Arizona has failed to pay up after arbitration — even in cases where the arbitrator chose the amount the insurance company proposed.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： U.K. decision on ALS drug has neurologists, advocates up in arms

WSS

J&J to emphasize cancer drugs, stop much of its vaccine research

Alzheimer's risk factor APOE4 may be a distinct form of the disease

U.K. Biobank has 500,000 peoples' genome sequences available

Gut bacteria may contribute to kidney autoimmunity, study finds

U.K. decision on ALS drug has neurologists, advocates up in arms

What don’t we know about an Alzheimer’s drug side effect?

leisure time

leisure time

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The EPA's new lead rule: How one expert crunched the numbers

United colonoscopy coverage change 'may cost lives,' doctors say

As biotech industry slumps, bioscience job market is upside down

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Drug repurposing or repositioning? The language matters

Will the market for weight loss drugs really reach $100 billion?

Medical leaders decry Supreme Court decision on affirmative action

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

hotspot

Bird flu in dairy cattle: New measures to control spread to humans

Researchers test human milk's ability to repair gut microbiome

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

Scientific mystery highlights the blind spots in genomics databases

Bird flu in dairy cattle: New measures to control spread to humans

Alzheimer's risk factor APOE4 may be a distinct form of the disease

knowledge

Wikipedia

explore

focus